Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Barbara Ann Burtness, Kevin Joseph Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro and 14 more
- Rank
- 84 of 3,866
- Percentile
- top 2.2%
- Where
- Annals of Oncology, 2018
- Citations
- 139
From the 2018 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.